After finishing at $56.74 in the prior trading day, Biohaven Ltd (NYSE: BHVN) closed at $56.95, up 0.37%. In other words, the price has increased by $+0.21 from its previous closing price. On the day, 2447981 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of BHVN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.98 and its Current Ratio is at 7.98. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on February 16, 2024, initiated with a Outperform rating and assigned the stock a target price of $62.
On February 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $59.
On December 22, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $50.H.C. Wainwright initiated its Buy rating on December 22, 2023, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 29 ’23 when Antonijevic Irina sold 11,000 shares for $41.79 per share. The transaction valued at 459,662 led to the insider holds 2,535 shares of the business.
CHILDS JOHN W bought 454,545 shares of BHVN for $9,999,990 on Oct 05 ’23. The Director now owns 3,998,952 shares after completing the transaction at $22.00 per share. On Oct 05 ’23, another insider, Coric Vlad, who serves as the Chief Executive Officer of the company, bought 340,908 shares for $22.00 each. As a result, the insider paid 7,499,976 and bolstered with 833,120 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 4.63B and an Enterprise Value of 4.28B.
Stock Price History:
The Beta on a monthly basis for BHVN is 4.16, which has changed by 340.11% over the last 52 weeks, in comparison to a change of 31.54% over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $62.21, while it has fallen to a 52-week low of $12.35. The 50-Day Moving Average of the stock is 49.18, while the 200-Day Moving Average is calculated to be 31.82.
Shares Statistics:
The stock has traded on average 1.19M shares per day over the past 3-months and 1.94M shares per day over the last 10 days, according to various share statistics. A total of 81.12M shares are outstanding, with a floating share count of 69.40M. Insiders hold about 14.45% of the company’s shares, while institutions hold 89.39% stake in the company. Shares short for BHVN as of Feb 29, 2024 were 7.73M with a Short Ratio of 6.49, compared to 6.69M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.48% and a Short% of Float of 10.80%.
Earnings Estimates
Its stock is currently analyzed by 9 different market analysts. On average, analysts expect EPS of -$1.55 for the current quarter, with a high estimate of -$1.27 and a low estimate of -$1.97, while EPS last year was -$1.03. The consensus estimate for the next quarter is -$1.58, with high estimates of -$1.24 and low estimates of -$1.95.
Analysts are recommending an EPS of between -$3.92 and -$7.96 for the fiscal current year, implying an average EPS of -$6.21. EPS for the following year is -$5.95, with 9 analysts recommending between -$3.85 and -$8.49.
